Back
Tekla Healthcare Opportunities Fund Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
25
THQ
Tekla Healthcare Opportunities Fund
Last Price:
21.98
Seasonality Move:
-1.36%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
60.97
Seasonality Move:
0.29%
Sell
25
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $21.92. The Score for THQ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $21.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THQ is experiencing slight selling pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight selling pressure.
THQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 59.26 | Buy |
Chaikin Money Flow: | -45585 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.4 - 21.82) | Buy |
Bollinger Bands (100): | (20.08 - 21.5) | Buy |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 52.65 | Buy |
Chaikin Money Flow: | -163397 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.84 - 62.92) | Buy |
Bollinger Bands (100): | (59.73 - 65.45) | Sell |
THQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.79 | Buy |
20-day SMA: | 21.68 | Buy |
50-day SMA: | 21.42 | Buy |
200-day SMA: | 19.88 | Buy |
8-day EMA: | 21.8 | Buy |
20-day EMA: | 21.67 | Buy |
50-day EMA: | 21.35 | Buy |
200-day EMA: | 20.16 | Buy |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.54 | Buy |
20-day SMA: | 60.34 | Buy |
50-day SMA: | 61.2 | Sell |
200-day SMA: | 61.23 | Sell |
8-day EMA: | 58.88 | Buy |
20-day EMA: | 59.62 | Buy |
50-day EMA: | 60.85 | Buy |
200-day EMA: | 60.54 | Buy |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |